News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Related Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Related Stories News Introducing Solodev AI: A Cloud Platform for Building, Training, and Hosting Custom AI Apps and Models – All in One Place News AutoScheduler.AI Mentioned in the 2024 Gartner® Technology Trends Transforming Warehousing — Part 2: Handling Volatility & Complexity report News Small Business Subchapter V Elections Increase 60 Percent In April Over the Same Period Last Year News UVify Sets New Guinness World Record With 5,293 IFO Drones in Spectacular Aerial Display News 2024 CAP Consumer Survey Shows Increase in Piracy on Social Media and Messaging Platforms in Asia Pacific News SDAI Limited: Positive Outcomes Since New Board took over in June 2023
